CreditReports.dk
HomeScreen companies

Clinical-Microbiomics A/S Financials, key figures and credit report

CVR number: 37230634 Established 2015 Industry: 72 Scientific research and development
Company contact details
Fruebjergvej 3, 2100 København Ø
Gross profit 2 831.0 kEUR FY 2025 +416.6% vs 2024
EBIT -2 641.0 kEUR FY 2025 +36.3% vs 2024
Net debt 3 164.0 kEUR FY 2025 +156.8% vs 2024
Quick ratio 0.8 FY 2025 -0.5 vs 2024

Income statement (kEUR)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit16 768.942 550.002 029.00548.002 831.00
Employee benefit expenses-16 806.21-3 098.00-3 632.00-4 062.00-4 600.00
Other operating expenses-3.00
Total depreciation-1 330.68- 202.00- 378.00- 632.00- 869.00
EBIT-1 367.95- 750.00-1 981.00-4 146.00-2 641.00
Other financial income19.009.0020.0012.00
Other financial expenses-1 181.97- 238.00- 115.00- 237.00- 102.00
Pre-tax profit-2 549.92- 969.00-2 087.00-4 363.00-2 731.00
Income taxes826.9542.00136.0035.00145.00
Net earnings-1 722.97- 927.00-1 951.00-4 328.00-2 586.00

Assets (kEUR)

2021
2022
2023
2024
2025
Development expenditure3 790.95854.001 369.001 939.001 277.00
Intangible assets total3 790.95854.001 369.001 939.001 277.00
Land and waters3 851.11360.00152.00
Buildings79.00
Machinery and equipment588.2175.0063.00119.0073.00
Tangible assets total4 439.32435.00215.00198.0073.00
Holdings in group member companies10 913.0083 186.0086 081.0086 010.00
Investments total340.1610 974.0083 252.0086 139.0086 048.00
Long term receivables total
Raw materials and consumables336.1982.00351.0054.00
Inventories total336.1982.00351.0054.00
Current trade debtors5 907.64619.001 816.001 188.001 257.00
Current amounts owed by group member comp.359.00565.00
Prepayments and accrued income1 516.96393.00863.0076.0070.00
Current other receivables312.21136.00258.00823.001 244.00
Current deferred tax assets1 002.1364.00137.00171.00171.00
Short term receivables total8 738.941 571.003 639.002 258.002 742.00
Other current investments3 984.00
Cash and bank deposits10 620.521 113.001 410.001 124.001 854.00
Cash and cash equivalents10 620.525 097.001 410.001 124.001 854.00
Balance sheet total (assets)28 266.0819 013.0090 236.0091 712.0091 994.00

Equity and liabilities (kEUR)

2021
2022
2023
2024
2025
Share capital704.30140.00271.00286.00286.00
Other reserves2 956.94667.001 069.001 516.00996.00
Retained earnings887.3416 168.0086 901.0090 559.0086 751.00
Profit of the financial year-1 722.97- 927.00-1 951.00-4 328.00-2 586.00
Shareholders equity total2 825.6116 048.0086 290.0088 033.0085 447.00
Non-current loans from credit institutions3 882.11770.00555.00277.00246.00
Non-current leasing loans4 131.30151.0057.0031.00
Non-current other liabilities159.18
Non-current deferred tax liabilities178.00182.00538.00178.00
Non-current liabilities total8 172.591 099.00737.00872.00455.00
Current loans from credit institutions2 675.90575.00399.00631.00520.00
Current trade creditors5 862.45887.002 389.00549.00271.00
Current owed to participating1 962.00
Current owed to group member1 448.002 290.00
Other non-interest bearing current liabilities5 677.79122.00240.00117.00571.00
Accruals and deferred income3 051.75282.00181.0062.00478.00
Current liabilities total17 267.891 866.003 209.002 807.006 092.00
Balance sheet total (liabilities)28 266.0819 013.0090 236.0091 712.0091 994.00
Page generated